Drug rings database with Web interface. A tool for identifying alternative chemical rings in lead discovery programs

Journal of Medicinal Chemistry

Volumn 46, Issue 15, 2003, Pages 3257-3274

  Lewell, Xiao Qing ^a   Jones, Andrew C ^a   Bruce, Craig L ^a   Harper, Gavin ^a   Jones, Matthew M ^a   McLay, Iain M ^a   Bradshaw, John ^b  

^a GLAXOSMITHKLINE   (United Kingdom)

^b Sheraton House   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENERGIC RECEPTOR STIMULATING AGENT; AG 555; AMOXICILLIN PLUS CLAVULANIC ACID; AY 30468; BELATIN; BIIP 20XX; CALCIUM CHANNEL BLOCKING AGENT; CERULEN; CHOLINESTERASE INHIBITOR; DOPAMINE 2 RECEPTOR BLOCKING AGENT; DOPAMINE RECEPTOR BLOCKING AGENT; FLUTICASONE PROPIONATE; FRI 172357; LEUKOTRIENE D4; LEUKOTRIENE RECEPTOR BLOCKING AGENT; PAROXETINE; RANITIDINE; ROSIGLITAZONE; SEROTONIN 2 ANTAGONIST; SERTINDOLE; SUMATRIPTAN SUCCINATE; ZAFIRLUKAST;

ANALYTIC METHOD; ARTICLE; CALCULATION; DATA BASE; DEVICE; DRUG STRUCTURE; GEOMETRY;

DATABASES, FACTUAL; DRUG DESIGN; ENDOTHELINS; HETEROCYCLIC COMPOUNDS; INDOLES; INTERNET; PHARMACEUTICAL PREPARATIONS;

EID: 0037479976     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm0300429     Document Type: Article

References (33)

1. PJB Publications Ltd., London. Web site: http://www.pjbpubs.com/.
2. Nilakantan, R.; Bauman, N.; Haraki, K. S.; Venkataraghavan, R. A ring-based chemical structural query system: use of a novel ring-complexity heuristic. J. Chem. Inf. Comput. Sci. 1990, 30 (1), 65-68.
3. Lipkus, A H. A Ring-Imbedding Index and Its Use in Substructure Searching. J. Chem. Inf. Comput. Sci. 1997, 37 (1), 92-97.
4. Lipkus, A H. Mining a large database for peptidomimetic ring structures using a topological index. J. Chem. Inf. Comput. Sci. 1999, 39 (3), 582-586.
5. Lipkus, A H. Exploring chemical rings in a simple topological-descriptor space. J. Chem. Inf. Comput. Sci. 2001, 41 (2), 430-438.
6. Nilakantan, R.; Bauman, N.; Haraki, K. S. Database diversity assessment: new ideas, concepts, and tools. J. Comput.-Aided Mol. Des. 1997, 11 (5), 447-452.
7. Hazeldine, S. T.; Polin, L.; Kushner, J.; White, K.; Bouregeois, N. M.; Crantz, B.; Palomino, E.; Corbett, T. H.; Horwitz, J. P. Synthesis and Biological Evaluation of Some Bioisosteres and Congeners of the Antitumor Agent, 2-{4-[(7-Chloro-2-quinoxalinyl)oxy]phenoxy}propionic Acid (XK469). J. Med. Chem. 2002, 45 (14), 3130-3137.
8. Gohlke, H.; Guendisch, D.; Schwarz, S.; Seitz, G.; Tilotta, M. C.; Wegge, T. Synthesis and Nicotinic Binding Studies on Enantiopure Diazine Analogues of the Novel (2-Chloro-5-pyridyl)-9-azabicyclo[4.2.1]non-2-ene UB-165. J. Med. Chem. 2002, 45 (5), 1064-1072.
9. Mederski, W. W. K. R.; Osswald, M.; Dorsch, D.; Anzali, S.; Christadler, M.; Schmitges, C.-J.; Wilm, C. 2. Endothelin antagonists: evaluation of 2,1,3-benzothiadiazole as a methylenedioxyphenyl bioisostere. Bioorg. Med. Chem. Lett. 1998, 8 (1), 17-22.
10. van Vliet, L. A.; Rodenhuis, N.; Dijkstra, D.; Wikstrom, H.; Pugsley, T. A.; Serpa, K. A.; Meltzer, L. T.; Heffner, T. G.; Wise, L. D.; Lajiness, M. E.; Huff, R. M.; Svensson, K.; Sundell, S.; Lundmark, M. Synthesis and pharmacological evaluation of thiopyran analogues of the dopamine D3 receptor-selective agonist (4aR,10bR)-(+)-trans-3,4,4a,10b-tetrahydro-4-n-propyl-2H,5H [1]benzopyrano[4,3-b]-1,4-oxazin-9-ol (PD 128907). J. Med. Chem. 2000, 43 (15), 2871-2882.
11. Sheridan, R. P. The most common chemical replacements in drug-like compounds. J. Chem. Inf. Comput. Sci. 2002, 42 (1), 103-108.
12. Molecular Design Drug Data Report, Version 99.1; Molecular Design Ltd.: San Leandro, CA.
13. Bemis, G. W.; Murcko, M. A. The Properties of Known Drugs. 1. Molecular Frameworks. J. Med. Chem. 1996, 39 (15), 2887-2893.
14. Bemis, G. W.; Murcko, M. A. Properties of known drugs. 2. Side chains. J. Med. Chem. 1999, 42 (25), 5095-5099.
15. Daylight Chemical Information Systems Inc. Web site: http:// www.daylight.com.
16. NCI96, National Cancer Institute Database. Web site: http:// www.nci.nih.gov/. NCI96 is a version supplied via Daylight Inc.
17. DNP102, Derwent Dictionary of Natural Product. Web site: http://www.derwent.com/.
18. WDI, Derwent World Drug Index. Web site: http:// www.derwent.com/worlddrugindex/index.html.
19. Mechem02, Medchem database, Pomona College and BioByte Corp., Claremont, CA. Database distributed by Daylight.
20. ACD014, MDL's Available Chemicals Directory. Web site: http:// www.mdli.com/products/acd.html.
21. Lauri, G.; Bartlett, P. A. CAVEAT: a program to facilitate the design of organic molecules. J Comput.-Aided Mol. Des. 1994, 8 (1), 51-66.
22. Boyd, S. M.; Beverley, M.; Norskov, L.; Hubbard, R. E. Characterizing the geometric diversity of functional groups in chemical databases. J. Comput.-Aided Mol. Des. 1995, 9 (5), 417-424.
23. Bohl, M.; Dunbar, J.; Gifford, E. M.; Heritage, T.; Wild, D. J.; Willett, P.; Wilton, D. J. Scaffold searching: Automated identification of similar ring systems for the design of combinatorial libraries. Quant. Struct.-Act. Relat. 2002, 21(6), 590-597.
24. Farmer, P. S., Ed. Arens Drug Design; Academic Press: New York, 1980; Vol. 10, pp 119-143.
25. Rusinko, A.; Skell, J. M.; Balducci, R.; McGarity, C. M.; Pearlman, R. S. CONCORD: a program for the rapid generation of high quality approximate 3D structures (developed at University of Texas at Austin); Version 4.0.4, Tripos Associates Inc., St. Louis, MO 63144.
26. Corina-Gasteiger, J.; Rudolph, C.; Sadowski, J. Automatic generation of 3D atomic coordinates for organic molecules. Tetrahedron Comput. Methodol. 1990, 3 (6c), 537-547.
27. Perregaard, J.; Arnt, J.; Boegesoe, K. P.; Hyttel, J.; Sanchez, C. Noncataleptogenic, centrally acting dopamine D-2 and serotonin 5-HT2 antagonists within a series of 3-substituted 1-(4-fluorophenyl)-1H-indoles. J. Med. Chem. 1992, 35 (6), 1092-1101.
28. Andersen, K.; Perregaard, J.; Arn, J.; Nielsen, J. B.; Begtrup, M. Selective, centrally acting serotonin 5-HT2 antagonists. 2. Substituted 3-(4-fluorophenyl)-1H-indoles. J. Med. Chem. 1992, 35 (26), 4823-4831.
29. Brown, M. F.; Marfat, A.; Antognoli, G.; Chambers, R. J.; Cheng, J. B.; Damon, D. B.; Liston, T. E.; McGlynn, M. A.; O'Sullivan, S. P.; Owens, B. S.; Pillar, J. S.; Shirley, J. T.; Watson, J. W. N-Carbamoyl analogs of Zafirlukast: potent receptor antagonists of leukotriene D4. Bioorg. Med. Chem. Lett. 1998, 8 (18), 2451-2456.
30. Brown, M. F. Preparation of bicyclic carbamates as LTD4 antagonists. U.S. Patent 5,439,929, 1995 (A 19,950,808; CAN 124:55946; AN 1995:793003 CAPLUS).
31. Anzali, S.; Mederski, W. W. K. R.; Osswald, M.; Dorsch, D. 1. Endothelin antagonists: search for surrogates of methylene-dioxyphenyl by means of a Kohonen neural network. Bioorg. Med. Chem. Lett. 1998, 8 (1), 11-16.
32. ASP 3.2 User Guide, 1997, Oxford Molecular Group (now Accelrys Inc.), Oxford, England. See references contained therein. For example, see the following. Burt, C.; Richards, W. G.; Huxley, P. The Application of Molecular Similarity Calculations. J. Comput. Chem. 1990, 11, 1139-1146.
33. TSAR, a QSAR product from Accelrys Inc. Web site: http://www.accelrys.com/.